Emergency Use
Authorization
COVID PLUS
PRESCREENING MONITOR
RAPID • NONINVASIVE • POINT OF CARE
HELP
BEAT
COVID
Early, rapid, non-invasive pre-screening tools will stop the spread of COVID-19 by identifying infected individuals.
For years our company, Tiger Tech, has been developing wearable sensor systems and researching disease state identification. On April 9, we knew that we had to help the world find an innovative solution for COVID-19 screening and testing.
"SUCCESSFULLY IDENTIFIES ASYMPTOMATIC SUBJECTS"
After years of research on disease states and months of research, on 1,000s of COVID subjects, our company developed a device called the COVID Plus: an armband with embedded sensors that acquire biometric signals from the body. This device is completely noninvasive. Over a period of 3 to 5 minutes, the COVID Plus Monitor checks for abnormalities in a
"TRACKS DISEASE PROGRESSION & INFECTIOUSNESS"
participant's biometrics, along with other COVID-19 complications.
The device uses hundreds of unique biomarkers to find patterns associated with COVID-19. This is a very similar process to facial pattern recognition programs that are used to unlock phones.
Positive and negative results are based on statistical analysis, specifically, the device analyzes where a user's biomarkers are positioned relative to thousands of COVID and NON-COVID subjects. Most importantly, these markers are present in COVID asymptomatic subjects.
The Tiger Tech COVID Plus is a game changer that will help stop the spread of COVID-19.
MEET THE COVID PLUS
The COVID Plus was developed by a team of physicians and engineers at one of the largest hospitals in the United States, Mount Sinai Medical Center (MSMC) in Miami Beach, Florida.
POWERFUL
The COVID Plus excels in identifying asymptomatic COVID positive subjects.
FAST
The COVID Plus takes less than 3 to 5 minutes to render a decision.
SIMPLE
Features a red or green indication.
SECURE
Does not require historical data or cloud computing, protecting your health information.
FRONT-LINE RESEARCH
Tiger Tech has studied the COVID Plus on thousands of COVID and NON-COVID subjects. The device has undergone pilot testing with hospital staff and patients; collegiate athletes and students; primary and secondary school students and faculty; and homeless shelter residents and staff. Prior to the COVID outbreak, studies were conducted on thousands of individuals for the purpose of disease state identification and human performance research.
CONTACT
US
